News

Eloxatin is a registered trademark of sanofi aventis US. It is an antineoplastic that works by killing cancer cells and slowing tumor growth, is a cancer medication that

PSE stated that gPROMS is used by process industry companies in the pharmaceutical, oil and gas, chemicals and petrochemicals, power generation, clean energy, food & beverage, consumer products

Canagliflozin, an investigational, oral, selective sodium-glucose transporter-2 (SGLT2) inhibitor, is a member of a new class of antihyperglycemic therapies under development to treat type 2 diabetes. Canagliflozin Phase

Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen’s research is developed by Roche. The compound is similar to the

Sanofi-aventis said that separate injections are being used by people following a basal-bolus insulin of a basal insulin and a mealtime insulin. The regimen is designed to address

Vpriv is Shire’s enzyme replacement therapy (ERT) for the treatment of type 1 Gaucher disease. Shire said that the CHMP positive opinion is expected to be forwarded to

Under the terms of the agreement, Lydall will provide Shrink with certain quantities of its Solupore thermoplastic membrane for the purpose of conducting a one-year research and development

Spherix said that reduction of triglyceride levels is a secondary endpoint of the Phase 3 trial. Results from the trial are expected later this summer. Spherix’s unblinded Phase

Octreolin is an oral form of octreotide acetate that uses the company’s proprietary Transient Permeability Enhancer (TPE) technology for the oral treatment of acromegaly. Chiasma said that if